Pyridoxalated haemoglobin polyoxyethylene conjugate, a nitric oxide scavenger, decreases dose-limiting hypotension associated with interleukin-2 (IL-2) therapy

Kazunori Murakami, Chris Privalle, Perenlei Enkhbaatar, Katsumi Shimoda, Frank C. Schmalstieg, Joseph DeAngelo, Steve Lee, Lillian D. Traber, Daniel L. Traber

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Interleukin-2 (IL-2), a cytokine that induces natural killer cells termed lymphokine-activated killer (LAK) cells, is in use as an anticancer agent. During IL-2 therapy, adverse effects, such as vasodilatation and hypotension, are common. Previous studies suggest that these effects are due to nitric oxide (NO). Therefore a model of IL-2-induced hyperdynamic response in sheep was developed to test the effect of pyridoxalated haemoglobin polyoxyethylene conjugate (PHP; a NO scavenger), which is currently in clinical development for the treatment of shock associated with systemic inflammatory response syndrome. Twelve female sheep were divided into four groups (n = 3 per group): sham control (Ringer's lactate solution), PHP alone (20 mg · kg-1 · h-1 for 96 h). IL-2 alone (recombinant human IL-2; I 440 000 units/kg intravenously every 8 h) and a combination of PHP and IL-2. All of the sheep received Ringer's lactate solution to maintain haematocrit at baseline levels. The sheep had free access to food and water. A fall in the mean arterial pressure and systemic vascular resistance index by 20% was observed in the IL-2 group, but not in the PHP+IL-2 group. The fluid requirement to maintain the haematocrit was higher in the IL-2 group (5 ml · kg-1 · h-1) than in the PHP+IL-2 group (4 ml · kg-1 · h-1). The sham group showed no changes in any of the parameters. Scavenging NO by PHP prevented the hyperdynamic reaction induced by IL-2 administration in sheep. This activity of PHP may prevent the early discontinuation of IL-2 therapy that results because of these adverse events.

Original languageEnglish (US)
Pages (from-to)629-635
Number of pages7
JournalClinical Science
Volume105
Issue number5
DOIs
StatePublished - Nov 2003

Fingerprint

Hypotension
Interleukin-2
Nitric Oxide
Sheep
Therapeutics
Hematocrit
pyridoxalated-hemoglobin-polyethylene glycol conjugate
Lymphokine-Activated Killer Cells
Systemic Inflammatory Response Syndrome
Interleukin-1
Vasodilation
Natural Killer Cells
Vascular Resistance
Antineoplastic Agents
Shock
Arterial Pressure
Cytokines
Food
Control Groups
Water

Keywords

  • Cytokine therapy
  • Lung oedema
  • Sheep
  • Systemic vascular resistance
  • Vascular leakage

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Pyridoxalated haemoglobin polyoxyethylene conjugate, a nitric oxide scavenger, decreases dose-limiting hypotension associated with interleukin-2 (IL-2) therapy. / Murakami, Kazunori; Privalle, Chris; Enkhbaatar, Perenlei; Shimoda, Katsumi; Schmalstieg, Frank C.; DeAngelo, Joseph; Lee, Steve; Traber, Lillian D.; Traber, Daniel L.

In: Clinical Science, Vol. 105, No. 5, 11.2003, p. 629-635.

Research output: Contribution to journalArticle

Murakami, Kazunori ; Privalle, Chris ; Enkhbaatar, Perenlei ; Shimoda, Katsumi ; Schmalstieg, Frank C. ; DeAngelo, Joseph ; Lee, Steve ; Traber, Lillian D. ; Traber, Daniel L. / Pyridoxalated haemoglobin polyoxyethylene conjugate, a nitric oxide scavenger, decreases dose-limiting hypotension associated with interleukin-2 (IL-2) therapy. In: Clinical Science. 2003 ; Vol. 105, No. 5. pp. 629-635.
@article{1a4be59d9c1d43eba1ad06837218b639,
title = "Pyridoxalated haemoglobin polyoxyethylene conjugate, a nitric oxide scavenger, decreases dose-limiting hypotension associated with interleukin-2 (IL-2) therapy",
abstract = "Interleukin-2 (IL-2), a cytokine that induces natural killer cells termed lymphokine-activated killer (LAK) cells, is in use as an anticancer agent. During IL-2 therapy, adverse effects, such as vasodilatation and hypotension, are common. Previous studies suggest that these effects are due to nitric oxide (NO). Therefore a model of IL-2-induced hyperdynamic response in sheep was developed to test the effect of pyridoxalated haemoglobin polyoxyethylene conjugate (PHP; a NO scavenger), which is currently in clinical development for the treatment of shock associated with systemic inflammatory response syndrome. Twelve female sheep were divided into four groups (n = 3 per group): sham control (Ringer's lactate solution), PHP alone (20 mg · kg-1 · h-1 for 96 h). IL-2 alone (recombinant human IL-2; I 440 000 units/kg intravenously every 8 h) and a combination of PHP and IL-2. All of the sheep received Ringer's lactate solution to maintain haematocrit at baseline levels. The sheep had free access to food and water. A fall in the mean arterial pressure and systemic vascular resistance index by 20{\%} was observed in the IL-2 group, but not in the PHP+IL-2 group. The fluid requirement to maintain the haematocrit was higher in the IL-2 group (5 ml · kg-1 · h-1) than in the PHP+IL-2 group (4 ml · kg-1 · h-1). The sham group showed no changes in any of the parameters. Scavenging NO by PHP prevented the hyperdynamic reaction induced by IL-2 administration in sheep. This activity of PHP may prevent the early discontinuation of IL-2 therapy that results because of these adverse events.",
keywords = "Cytokine therapy, Lung oedema, Sheep, Systemic vascular resistance, Vascular leakage",
author = "Kazunori Murakami and Chris Privalle and Perenlei Enkhbaatar and Katsumi Shimoda and Schmalstieg, {Frank C.} and Joseph DeAngelo and Steve Lee and Traber, {Lillian D.} and Traber, {Daniel L.}",
year = "2003",
month = "11",
doi = "10.1042/CS20030164",
language = "English (US)",
volume = "105",
pages = "629--635",
journal = "Clinical Science",
issn = "0143-5221",
publisher = "Portland Press Ltd.",
number = "5",

}

TY - JOUR

T1 - Pyridoxalated haemoglobin polyoxyethylene conjugate, a nitric oxide scavenger, decreases dose-limiting hypotension associated with interleukin-2 (IL-2) therapy

AU - Murakami, Kazunori

AU - Privalle, Chris

AU - Enkhbaatar, Perenlei

AU - Shimoda, Katsumi

AU - Schmalstieg, Frank C.

AU - DeAngelo, Joseph

AU - Lee, Steve

AU - Traber, Lillian D.

AU - Traber, Daniel L.

PY - 2003/11

Y1 - 2003/11

N2 - Interleukin-2 (IL-2), a cytokine that induces natural killer cells termed lymphokine-activated killer (LAK) cells, is in use as an anticancer agent. During IL-2 therapy, adverse effects, such as vasodilatation and hypotension, are common. Previous studies suggest that these effects are due to nitric oxide (NO). Therefore a model of IL-2-induced hyperdynamic response in sheep was developed to test the effect of pyridoxalated haemoglobin polyoxyethylene conjugate (PHP; a NO scavenger), which is currently in clinical development for the treatment of shock associated with systemic inflammatory response syndrome. Twelve female sheep were divided into four groups (n = 3 per group): sham control (Ringer's lactate solution), PHP alone (20 mg · kg-1 · h-1 for 96 h). IL-2 alone (recombinant human IL-2; I 440 000 units/kg intravenously every 8 h) and a combination of PHP and IL-2. All of the sheep received Ringer's lactate solution to maintain haematocrit at baseline levels. The sheep had free access to food and water. A fall in the mean arterial pressure and systemic vascular resistance index by 20% was observed in the IL-2 group, but not in the PHP+IL-2 group. The fluid requirement to maintain the haematocrit was higher in the IL-2 group (5 ml · kg-1 · h-1) than in the PHP+IL-2 group (4 ml · kg-1 · h-1). The sham group showed no changes in any of the parameters. Scavenging NO by PHP prevented the hyperdynamic reaction induced by IL-2 administration in sheep. This activity of PHP may prevent the early discontinuation of IL-2 therapy that results because of these adverse events.

AB - Interleukin-2 (IL-2), a cytokine that induces natural killer cells termed lymphokine-activated killer (LAK) cells, is in use as an anticancer agent. During IL-2 therapy, adverse effects, such as vasodilatation and hypotension, are common. Previous studies suggest that these effects are due to nitric oxide (NO). Therefore a model of IL-2-induced hyperdynamic response in sheep was developed to test the effect of pyridoxalated haemoglobin polyoxyethylene conjugate (PHP; a NO scavenger), which is currently in clinical development for the treatment of shock associated with systemic inflammatory response syndrome. Twelve female sheep were divided into four groups (n = 3 per group): sham control (Ringer's lactate solution), PHP alone (20 mg · kg-1 · h-1 for 96 h). IL-2 alone (recombinant human IL-2; I 440 000 units/kg intravenously every 8 h) and a combination of PHP and IL-2. All of the sheep received Ringer's lactate solution to maintain haematocrit at baseline levels. The sheep had free access to food and water. A fall in the mean arterial pressure and systemic vascular resistance index by 20% was observed in the IL-2 group, but not in the PHP+IL-2 group. The fluid requirement to maintain the haematocrit was higher in the IL-2 group (5 ml · kg-1 · h-1) than in the PHP+IL-2 group (4 ml · kg-1 · h-1). The sham group showed no changes in any of the parameters. Scavenging NO by PHP prevented the hyperdynamic reaction induced by IL-2 administration in sheep. This activity of PHP may prevent the early discontinuation of IL-2 therapy that results because of these adverse events.

KW - Cytokine therapy

KW - Lung oedema

KW - Sheep

KW - Systemic vascular resistance

KW - Vascular leakage

UR - http://www.scopus.com/inward/record.url?scp=0242469104&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242469104&partnerID=8YFLogxK

U2 - 10.1042/CS20030164

DO - 10.1042/CS20030164

M3 - Article

VL - 105

SP - 629

EP - 635

JO - Clinical Science

JF - Clinical Science

SN - 0143-5221

IS - 5

ER -